BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 30302507)

  • 1. A density assignment method for dose monitoring in head-and-neck radiotherapy.
    Barateau A; Perichon N; Castelli J; Schick U; Henry O; Chajon E; Simon A; Lafond C; De Crevoisier R
    Strahlenther Onkol; 2019 Feb; 195(2):175-185. PubMed ID: 30302507
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Nomogram to predict parotid gland overdose in head and neck IMRT.
    Castelli J; Simon A; Rigaud B; Lafond C; Chajon E; Ospina JD; Haigron P; Laguerre B; Loubière AR; Benezery K; de Crevoisier R
    Radiat Oncol; 2016 Jun; 11():79. PubMed ID: 27278960
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of head and neck cancer adaptive radiotherapy to spare the parotid glands and decrease the risk of xerostomia.
    Castelli J; Simon A; Louvel G; Henry O; Chajon E; Nassef M; Haigron P; Cazoulat G; Ospina JD; Jegoux F; Benezery K; de Crevoisier R
    Radiat Oncol; 2015 Jan; 10():6. PubMed ID: 25573091
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of CBCT-based dose calculation methods in head and neck cancer radiotherapy: from Hounsfield unit to density calibration curve to deep learning.
    Barateau A; De Crevoisier R; Largent A; Mylona E; Perichon N; Castelli J; Chajon E; Acosta O; Simon A; Nunes JC; Lafond C
    Med Phys; 2020 Oct; 47(10):4683-4693. PubMed ID: 32654160
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Optimal adaptive IMRT strategy to spare the parotid glands in oropharyngeal cancer.
    Zhang P; Simon A; Rigaud B; Castelli J; Ospina Arango JD; Nassef M; Henry O; Zhu J; Haigron P; Li B; Shu H; De Crevoisier R
    Radiother Oncol; 2016 Jul; 120(1):41-7. PubMed ID: 27372223
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Monitoring dosimetric impact of weight loss with kilovoltage (kV) cone beam CT (CBCT) during parotid-sparing IMRT and concurrent chemotherapy.
    Ho KF; Marchant T; Moore C; Webster G; Rowbottom C; Penington H; Lee L; Yap B; Sykes A; Slevin N
    Int J Radiat Oncol Biol Phys; 2012 Mar; 82(3):e375-82. PubMed ID: 22197229
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Near Real-Time Assessment of Anatomic and Dosimetric Variations for Head and Neck Radiation Therapy via Graphics Processing Unit-based Dose Deformation Framework.
    Qi XS; Santhanam A; Neylon J; Min Y; Armstrong T; Sheng K; Staton RJ; Pukala J; Pham A; Low DA; Lee SP; Steinberg M; Manon R; Chen AM; Kupelian P
    Int J Radiat Oncol Biol Phys; 2015 Jun; 92(2):415-22. PubMed ID: 25847607
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Parotid glands dose-effect relationships based on their actually delivered doses: implications for adaptive replanning in radiation therapy of head-and-neck cancer.
    Hunter KU; Fernandes LL; Vineberg KA; McShan D; Antonuk AE; Cornwall C; Feng M; Schipper MJ; Balter JM; Eisbruch A
    Int J Radiat Oncol Biol Phys; 2013 Nov; 87(4):676-82. PubMed ID: 24035328
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of the effectiveness of novel single-intervention adaptive radiotherapy strategies based on daily dose accumulation.
    Ciarmatori A; Maffei N; Mistretta GM; Ceroni P; Bernabei A; Meduri B; D'Angelo E; Bruni A; Giacobazzi P; Lohr F; Guidi G
    Med Dosim; 2019 Winter; 44(4):379-384. PubMed ID: 30871864
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of unified intensity-modulated arc therapy for the radiotherapy of head-and-neck cancer.
    MacFarlane M; Hoover DA; Wong E; Read N; Palma D; Venkatesan V; Hammond A; Battista JJ; Chen JZ
    Radiother Oncol; 2016 May; 119(2):331-6. PubMed ID: 27041142
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of intravenous contrast agent on dose calculations of intensity modulated radiation therapy plans for head and neck cancer.
    Choi Y; Kim JK; Lee HS; Hur WJ; Hong YS; Park S; Ahn K; Cho H
    Radiother Oncol; 2006 Nov; 81(2):158-62. PubMed ID: 17050020
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Implementation of an optimization method for parotid gland sparing during inverse planning for head and neck cancer radiotherapy.
    Delaby N; Martin S; Barateau A; Henry O; Perichon N; De Crevoisier R; Chajon E; Castelli J; Lafond C
    Cancer Radiother; 2020 Feb; 24(1):28-37. PubMed ID: 32007370
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adaptive replanning strategies accounting for shrinkage in head and neck IMRT.
    Wu Q; Chi Y; Chen PY; Krauss DJ; Yan D; Martinez A
    Int J Radiat Oncol Biol Phys; 2009 Nov; 75(3):924-32. PubMed ID: 19801104
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CT-based dose recalculations in head and neck cancer radiotherapy: comparison of daily dose recalculations to less time-consuming approaches.
    Wagenblast S; Kampfer S; Borm KJ; Combs SE; Pigorsch SU; Duma MN
    Strahlenther Onkol; 2019 Jun; 195(6):475-481. PubMed ID: 30523417
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Repeat CT imaging and replanning during the course of IMRT for head-and-neck cancer.
    Hansen EK; Bucci MK; Quivey JM; Weinberg V; Xia P
    Int J Radiat Oncol Biol Phys; 2006 Feb; 64(2):355-62. PubMed ID: 16256277
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative analysis of an image-guided versus a non-image-guided setup approach in terms of delivered dose to the parotid glands in head-and-neck cancer IMRT.
    Duma MN; Kampfer S; Wilkens JJ; Schuster T; Molls M; Geinitz H
    Int J Radiat Oncol Biol Phys; 2010 Jul; 77(4):1266-73. PubMed ID: 20350787
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Parotid gland radiation dose-xerostomia relationships based on actual delivered dose for nasopharyngeal carcinoma.
    Lou J; Huang P; Ma C; Zheng Y; Chen J; Liang Y; Li H; Yin Y; Liu D; Yu G; Li D
    J Appl Clin Med Phys; 2018 May; 19(3):251-260. PubMed ID: 29664218
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Volume changes during head-and-neck radiotherapy and its impact on the parotid dose - A single-institution observational study.
    Ilangovan B; Venkatraman M; Balasundaram S
    J Cancer Res Ther; 2020; 16(3):575-580. PubMed ID: 32719270
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rules of parotid gland dose variations and shift during intensity modulated radiation therapy for nasopharyngeal carcinoma.
    Wang W; Yang H; Mi Y; Hu W; Ding W; Xie Y; Cai Y; Chen X
    Radiat Oncol; 2015 Jan; 10():3. PubMed ID: 25566789
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Parotid glands dose-effect relationships based on their actually delivered doses: implications for adaptive replanning in radiation therapy of head-and-neck cancer: in regard to Hunter et al.
    Ren G; Ma L; Xu S
    Int J Radiat Oncol Biol Phys; 2014 Apr; 88(5):1213-4. PubMed ID: 24661675
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.